SCHEMBL30108295

SCHEMBL30108295

COC(=O)N1CCC2(OCCO2)C(C=O)C1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.35
USP2 O75604 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 3/20 0.35
ALDH1A1 P00352 3/20 0.34
POLB P06746 2/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CYP3A4 P08684 5/20 0.33
CYP2C19 P33261 4/20 0.33
KMT2A Q03164 3/20 0.33
MAPK1 P28482 2/20 0.33
MEN1 O00255 1/20 0.33
HSD17B10 Q99714 2/20 0.33
TSHR P16473 2/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108302 0.78 POLB (0.38) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL30108294 0.77 CYP2D6 (0.38) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL2081988 0.70 KMT2A (0.54) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL22163904 0.68 PDK1 (0.40) USP2ALDH1A1CHRNB2CHRNA4CHRNB4
SCHEMBL22163907 0.68 PDK1 (0.40) USP2ALDH1A1CHRNB2CHRNA4CHRNB4
SCHEMBL5006363 0.65 CHRNB2 (0.42) CYP2C9CYP2D6CHRNB2CHRNA4CHRNB4
SCHEMBL5746952 0.65 CYP2C9 (0.40) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL3055828 0.65 CYP3A4 (0.40) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL3616921 0.65 EPHX1 (0.38) CYP2C9USP2CYP1A2CYP2D6ALDH1A1
SCHEMBL17608815 0.64 USP2 (0.35) CYP2C9USP2CYP1A2CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113549068-B Novel imidazopyridine compound, preparation method and medical application thereof 上海拓界生物医药科技有限公司 2022-12-02 CN disclosed